AEMD (Aethlon Medical Corp) חוב כולל להון
The price history of Aethlon Medical (AEMD) on the GURU.Markets platform, where the indicator stands at 0.07, is based on the brand's waste recycling efforts and plant energy efficiency. High authority within the scientific community, driven by innovative plasma purification, supports the quotes. Growth prospects rely on the success of Hemopurifier filter clinical trials, the acquisition of new patents, and government funding.
%20-%20%D7%99%D7%97%D7%A1%20%D7%9B%D7%9C%D7%9C%20%D7%94%D7%97%D7%95%D7%91%D7%95%D7%AA%20%D7%9C%D7%9E%D7%A7%D7%95%D7%A8%D7%95%D7%AA%20%D7%A2%D7%A6%D7%9E%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_AEMD_-_Aethlon-Medical_-_All-Debt-to-Shareholders-Equity-Ratio "AEMD (Aethlon) היסטוריית חוב כולל להון מ-04.07.2022 עד 29.10.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים ודוחות נתונים של חברת Aethlon Medical Corp (AEMD)
This ratio measures the proportion of borrowed funds within the financing structure, determining the business's degree of financial autonomy and its resilience to market shocks. By analyzing changes in the total debt-to-equity ratio, investors assess the ability of Aethlon Medical (AEMD) to fund costly clinical trials and the implementation of blood purification filters without critical dependence on external creditors.